|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.09 USD | -0.93% |
|
-0.87% | +9.62% |
| 07-30 | Keros Therapeutics to Receive $20 Million Development Milestone Payment From Takeda | DJ |
| 07-30 | Takeda Pharmaceutical Company Limited, Q1 2027 Earnings Call, Jul 30, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,024B | |||||
| 618B | |||||
| 443B | |||||
| 349B | |||||
| 297B |
Select your edition
All financial news and data tailored to specific country editions
